Jaromir Novak

Jaromir Novak

Auto-generated profile, based on publicly available information

Jaromir Novak

Institute of Biotechnology, Czech Academy of Sciences, Prague-West, Czech Republic

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2025 in Oncogene
Verified
Journal Article
Open access
PDF file
PBPetra Brisudova
Petra Brisudova
DSDana Stojanovic
Dana Stojanovic
JNJan Novak
Jan Novak
ZNZuzana Nahacka
Zuzana Nahacka
GOGabriela Lopes Oliveira
Gabriela Lopes Oliveira
JNJiri Neuzil
Jiri Neuzil
Horizontal transfer of mitochondria from the tumour microenvironment to cancer cells to support proliferation and enhance tumour progression has been shown for various types of cancer in recent years. Glioblastoma, the most aggressive adult brain tumour, has proven to be no exception when it comes to dynamic intercellular mitochondrial movement, as shown in this study using an orthotopic tumour model of respiration-deficient glioblastoma cells. Although confirmed mitochondrial transfer was shown to facilitate tumour progression in glioblastoma, we decided to investigate whether the related electron transport chain recovery is necessary for tumour formation in the brain. Based on experiments using time-resolved analysis of tumour formation by glioblastoma cells depleted of their mitochondrial DNA, we conclude that functional mitochondrial respiration is essential for glioblastoma growth in vivo, because it is needed to support coenzyme Q redox cycling for de novo pyrimidine biosynthesis controlled by respiration-linked dihydroorotate dehydrogenase enzyme activity. We also demonstrate here that astrocytes are key mitochondrial donors in this model.

1 October 2005 in Journal of Dental Research
Verified
Journal Article
Closed access
PDF file
JNJan Novak
Jan Novak
MTM. Tomana
M. Tomana
GSG.R. Shah
G.R. Shah
RBR. Brown
R. Brown
JMJ. Mestecky
J. Mestecky
Periodontal disease is a chronic inflammatory disease of bacterial etiology. In many other chronic inflammatory diseases, IgG glycans are galactose-deficient and thus capable of complement activation through the lectin pathway. In this study, we examined whether IgG in serum and gingival crevicular fluid, and IgG locally produced by plasma cells in gingiva of periodontal disease patients, display altered glycosylation. We developed a lectin-ELISA to measure levels of galactose-deficient IgG in the fluids and immunofluorescence staining to detect galactose-deficient IgG-producing cells in gingiva. Our results indicated higher levels of galactose-deficient IgG in sera and gingival crevicular fluid from periodontal disease patients, compared with levels in healthy controls. Furthermore, gingivae from periodontal disease patients exhibited infiltration of IgG-producing plasma cells; many of them contained galactose-deficient IgG in the cytoplasm. Analysis of our data suggests that IgG secreted by B-cells was aberrantly glycosylated, which resulted in the production of pro-inflammatory galactose-deficient IgG.

17 November 2025 in Cancer Research
Verified
Journal Article
Open access
MDMaria Dubisova
Maria Dubisova
KBKlara Bohacova
Klara Bohacova
ZNZuzana Nahacka
Zuzana Nahacka
DKDaniel Kraus
Daniel Kraus
JNJan Novak
Jan Novak
JNJiri Neuzil
Jiri Neuzil
Cancer cells with severe defects in mitochondrial DNA (mtDNA) can import mitochondria via horizontal mitochondrial transfer to restore respiration. Mitochondrial respiration is necessary for the activity of dihydroorotate dehydrogenase (DHODH), an enzyme of the inner mitochondrial membrane that catalyzes the fourth step of de novo pyrimidine synthesis. In this study, we investigated the role of de novo synthesis of pyrimidines in driving tumor growth in mtDNA-deficient (ρ0) cells. Although ρ0 cells grafted in mice readily acquired mtDNA, this process was delayed in cells transfected with alternative oxidase (AOX), which combines the functions of mitochondrial respiratory complexes III and IV. The ρ0 AOX cells were glycolytic but maintained normal DHODH activity and pyrimidine production. Deletion of DHODH in a panel of tumor cells completely blocked or delayed tumor growth. The grafted ρ0 cells rapidly recruited tumor-promoting/stabilizing cells of the innate immune system, including protumor M2 macrophages, neutrophils, eosinophils, and mesenchymal stromal cells (MSC). The ρ0 cells recruited MSCs early after grafting, which were potential mitochondrial donors. Grafting MSCs together with ρ0 cancer cells into mice resulted in mitochondrial transfer from MSCs to cancer cells. Overall, these findings indicate that cancer cells with compromised mitochondrial function readily acquire mtDNA from other cells in the tumor microenvironment to restore DHODH-dependent respiration and de novo pyrimidine synthesis. The inhibition of tumor growth induced by blocking DHODH supports targeting pyrimidine synthesis as a potential widely applicable therapeutic approach. Significance: Mitochondrial complexes III and IV promote tumor progression by supporting de novo pyrimidine synthesis, requiring cancer cells devoid of mitochondrial DNA to recruit mitochondria from source cells to restore respiration in order to form tumors.

1 September 1991 in Journal of Chromatography A
Verified
Journal Article
Closed access
MBMilos Beran
Milos Beran
VPV. Přikrylová
V. Přikrylová
PSP. Sedmera
P. Sedmera
JNJan Novak
Jan Novak
JZJ. Zima
J. Zima
TTT.Kh. Todorov
T.Kh. Todorov

15 May 2025 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Open access
GOGabriela L. Oliveira
Gabriela L. Oliveira
JNJan Novak
Jan Novak
ZNZuzana Nahacka
Zuzana Nahacka
PBPetra Brisudova
Petra Brisudova
Sandra MotaSandra Mota
Sandra Mota
RMRicardo Marques
Ricardo Marques
Although controversial, cancer stem cells (CSCs) are thought to be one tumor component, being characterized by their strong self-renewal and survival properties. Cancer cells, CSCs included, are thought to rely mostly on glycolysis, even in the presence of oxygen, which confers them adaptive advantages. Adenine nucleotide translocator 2 (ANT2), responsible for the exchange of ADP and ATP in the mitochondrial inner membrane, has been correlated with a higher glycolytic metabolism and is known to be overexpressed in cancer cells. Using P19 embryonal carcinoma stem cells, we inhibited ANT2 translation by using siRNA. ANT2 protein levels were shown to be overexpressed in P19 undifferentiated cells (P19SCs) when compared to their differentiated counterparts (P19dCs). Furthermore, we showed here that the OXPHOS machinery and mitochondrial membrane potential are compromised after ANT2 depletion, leading to a metabolic adaptation towards a less oxidative phenotype. Interestingly, hexokinase II levels were downregulated, which was also accompanied by decreased cell growth, and reduced ability to form spheroids. Our findings underscore ANT2 as a key regulator of metabolic remodeling and cell survival of cancer stem-like cells, suggesting its potential as a therapeutic target for controlling CSC-driven tumor progression.

4 June 2025 in Oncogene
Verified
Journal Article
Open access
PBPetra Brisudova
Petra Brisudova
DSDana Stojanovic
Dana Stojanovic
JNJan Novak
Jan Novak
ZNZuzana Nahacka
Zuzana Nahacka
GOGabriela Lopes Oliveira
Gabriela Lopes Oliveira
JNJiri Neuzil
Jiri Neuzil